| Indication | Used to prevent and treat nausea and vomiting associated with anesthesia and surgery, administered intramuscularly or intravenously. |
| Pharmacodynamics | Benzquinamide is an antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. |
| Mechanism of action | The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors. |
| Absorption | Incomplete, with 33–39% bioavailability via the capsule and suppository routes, relative to the intramuscular route. |
| Volume of distribution | Not Available |
| Protein binding | Not Available |
| Metabolism | Not Available |
| Route of elimination | Not Available |
| Half life | 1-1.6 hours (for all formulations) |
| Clearance | Not Available |
| Toxicity | Not Available |
No comments:
Post a Comment